The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Psychiatry & PsychotherapyFull Access

California Approves Law Granting Pretrial Diversion for BPD

Borderline personality disorder (BPD) is a serious mental illness that affects about 1.6% of the population. Approximately 70% of people with BPD experience a suicide attempt and, sadly, 10% die by suicide. Although major strides have been made in diagnosing and treating this condition, it is still subject to unwarranted stigma, among not only providers but also the broader society, including those who live with BPD themselves.

Individuals with BPD are often wrongfully depicted as manipulative, wildly irrational, and invariably destructive. These stereotypes do not acknowledge either the inner suffering or the assets that people with BPD have. The stigma impedes a more hopeful, multi-dimensional, person-centered narrative.

Internalizing stigma can reinforce feelings of rejection or hopelessness, which can make individuals living with BPD less likely to seek professional help or social support in a crisis. With treatment and support, more than 90% of people recover from BPD and experience symptom remission to live a meaningful life. The problem, however, is that the vast majority of people with BPD have difficulties accessing treatment due to barriers such as an inadequate number of therapists practicing the evidence-based treatments, the cost of treatment, and lack of insurance coverage. Stigma also contributes to continued suffering and the risk of suicide, as well as other social problems such as housing insecurity, incarceration, and unemployment.

In response to this ongoing crisis, several advocacy organizations, including Emotions Matter, the National Education Alliance for Borderline Personality Disorder, and the California Council of Community Behavioral Health Agencies (CBHA)—joined forces to address the problem of stigma through a groundbreaking effort to remove stigma in California law.

Since 2018, the California Penal Code 1001.36 has allowed pretrial diversion for individuals diagnosed with certain mental health conditions, including schizophrenia, bipolar disorder, and posttraumatic stress disorder. Until now, people with BPD, along with people with antisocial personality disorder, were excluded from receiving pretrial diversion services designed to reduce the likelihood of reoffending and to facilitate their safe community reintegration.

On October 10, 2023, Gov. Gavin Newsom of California took a significant step by signing AB 1412 into law. This new legislation eliminates the exclusion of BPD from the pretrial prison diversion bill.

Assembly member Gregg Hart, who represents California’s 37th Assembly District, stated: “Upon being informed about this bill proposal by a CBHA member residing in my district, I promptly became troubled by the prejudice against individuals with borderline personality disorder. California’s legal framework must provide individuals with BPD the chance to engage in pretrial diversion and progress toward a productive, satisfying life. I take pride in being the author of this bill and the prospects it will provide to those living with BPD.”

The approval of AB 1412 highlights the considerable impact that grassroots advocacy can have on legislative initiatives to improve access and equity in BPD treatment. Additionally, it underscores the vital role that mental health professionals can play in shaping more inclusive and effective policies for highly stigmatized psychological disorders like BPD.

Passing AB 1412 is significant because it represents the first policy passed to address stigmatizing mental health policy against people with BPD. Hundreds of people living with BPD, in conjunction with family members and clinicians, mobilized from around the country to ensure that people with BPD be treated the same as people with other mental health conditions in the California penal system.

Historically, advocacy efforts for various mental health conditions were often led by consumers and clinicians who relied on advancements in science and medicine to combat stigma. This advocacy is now expanding to support individuals with BPD. The rise of social media has empowered a growing number of young people to openly discuss BPD. They are ready to tell individuals with stigmatized views that now is the time to change. They are empowered to speak up about their condition and claim their right under the Mental Health Parity and Addiction Equity Act to access care. They want to live and recover, just like Americans with other psychiatric conditions.

The passage of California AB 1412 illustrates that the tide regarding stigma is turning. Other governmental bodies, health care professionals, people with lived experience, and insurance companies now need to follow suit and recognize BPD for what it is: a serious mental illness in need of research, education, and accessible treatment. Passing AB 1412 can be regarded as an encouraging start. ■

Resources

APA urges you to become involved with advocacy; staff in APA’s Division of Government Relations will work with you and provide helpful tools. Sign up for APA’s Advocacy Alerts and join the Congressional Advocacy Network.

For more information, email APA’s Division of Government Relations.

Photos of Frank Yeomans, M.D., Ph.D., Paula Tusiani-Eng, L.M.S.W., and  Kellyanne Navarre, B.A.

Frank Yeomans, M.D., Ph.D., is a clinical associate professor of psychiatry at Weill Medical College of Cornell University and a lecturer at the Columbia University Center for Psychoanalytic Training and Research.

Paula Tusiani-Eng, L.M.S.W., is co-founder and executive director of Emotions Matter, a nonprofit organization to support, educate, and advocate for people impacted by borderline personality disorder.

Kellyanne Navarre, B.A., is the research study coordinator in the Mood and Emotion Regulation Laboratory at Cleveland State University.

This article is part of a series by the Group for the Advancement of Psychiatry’s Committee on Psychotherapy, of which Yeomans is a member.